Yazar "Suveren, E." seçeneğine göre listele

Listeleniyor 1 - 1 / 1
  • Küçük Resim Yok
    Öğe
    The effects of leptin on the cardiovascular system
    (Nova Science Publishers, Inc., 2023) Kiliç, U.; Soytürk, H.; Suveren, E.; Yildiz, A.
    Leptin hormone is an adipokine released from adipose tissue that has recently gained interest due to its impact on the cardiovascular system as well as many other systemic effects. The obesity (ob) gene regulates leptin hormone release, which plays a role in body fat regulation. Obesity, which is defined by a rise in blood leptin levels, is a key risk factor for cardiovascular disease. Because of the increased activity of the sympathetic nervous system and the accompanying renin-angiotensin system, obesity produces a rise in extracellular fluid volume. The increase in sympathetic activity caused by hyperleptinemia is one of the reasons for obesity-related hypertension. One of the reasons for cardiovascular diseases in obesity is the interplay of angiotensin II, insulin, endothelin-A, and hyperleptinemia. Acute cardiovascular events, restenosis following coronary angioplasty, and cerebral palsy have all been linked to high leptin levels. In leptin-deficient mice, arterial thrombosis was shown to be minimal. As a result, inhibiting leptin activation could be a future therapy method for hyperleptinemic obese people to reduce the course of atherosclerosis. This book chapter will discuss the consequences of hyperleptinemia caused by high leptin serum levels and leptin receptor resistance in obesity on renal, cardiac, vascular, and sympathetic nervous system function, as well as their relationship to cardiovascular disease. © 2024 by Nova Science Publishers, Inc. All rights reserved.